Press Releases

CHOOSE A YEAR
2024-01-24

„AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement“

The cooperation provides us with the opportunity to combine exceptional German antiviral research with our development capabilities and clinical expertise to develop novel therapies for immunocompromised patients.

2024-01-09

AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS®

PREVYMIS® received european approval for prophylaxis of Cytomegalovirus (CMV) disease in adult kidney transplant recipients at high risk.